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The Relevance of Anesthetic Drug–Induced Neurotoxicity
TomG. Hansen, MD, PhD; Thomas Engelhardt, MD, PhD; MarkusWeiss, MD, PhD
Preclinical studies1-3 in young animals have demonstrated
neurodegeneration and subsequent neurocognitive impair-
ment for virtually all clinically available general anesthetic
drugs.However, comparative human studies on this issue are
scarce and inconclusive.
Several reasons account for this discrepancy. First,
preclinical animal studies were never driven by a clinical
suspicion of neurocognitive deficits associated with expo-
sure to anesthetic drugs in early life. There is no well-
defined and specific long-
term phenotype associated
with exposure to anesthetic
drugs. The first preclinical
investigations were extrapolated from findings related to
fetal alcohol syndrome and long-term fetal exposure to anti-
epileptic drugs.3 An a priori expectation that anesthetic
drugs also would be neurodegenerative in comparable
experimental settings was based on the putative (but
unknown) mechanisms of actions of anesthetics.3 A large
number of studies, reviews, and commentaries have since
been published as a result.4,5
Therearemanychallenges thatneed tobeovercomewhen
translating animal studies into a human context.3,6 If expo-
sure to anesthetic drugs was indeed as harmful in early hu-
man life as hypothesized,4,5 this effect would most likely
have been suspected many years ago.
Someobservational cohort studies7-9 have demonstrated
anassociationbetweennegative long-termneurocognitiveout-
comes in young children exposed to anesthesia (and sur-
gery), perpetuating any anxiety. Most of these observational
investigations are fromsingle centers (prone to selectionbias)
reportingonsmall sample sizeswith largeage ranges (andvery
few neonates and infants) and a multitude of surgical proce-
dures. Inconsistent outcomemeasures confuse thepublic and
professionals alike, resulting in a failure to demonstrate a hu-
man corollary to this animal phenomenon. However, what
constitutes a meaningful human outcome measure? What is
important for the child, the parent, and the public interest?
The most commonly reported neurocognitive outcome
measures inhumansare IQ, learningdisabilities, academicper-
formance, neuropsychiatric disorders (autism and attention-
deficit/hyperactivity disorder), and individual neuropsycho-
logical test results (eg,BayleyandWechsler scores).3Allof these
outcomemeasures have limitations. A global neurocognitive
decline (affecting IQ, learningdisabilities,andattention-deficit/
hyperactivity disorder) may be the consequence of an indis-
criminate effect of anesthetic drugs. If specific brain areas are
damaged during susceptible developmental times, the rel-
evantneurological outcomemaybe subtle (eg, reading, speak-
ing, attention, and fine motor movements).10 However, the
most important aspects of these outcomemeasures for a fam-
ily are neglected. How well does a single short-term interim
measure performed in early childhood or adolescence ad-
equately predict outcome and social functioning later in life,
andwhat are the long-termconsequences?Towhat extent are
sensorimotor deficits3 relevant?
Learningdisabilitiesare ill definedand influencedbymany
underlying circumstances, such as chronic diseases and envi-
ronmental factors. They are a nonspecific neuropsychological
outcome measure and are categorized according to the pre-
dicted and actual educational achievement. Extensive and re-
peated neurodevelopmental testing is sensitive enough to de-
tect smaller, more minor neurocognitive impairments after
anesthesia.11 Studies thatuse individually administeredcogni-
tive testsaremore likely todetectapotentialphenotype (eg,ab-
normalities in speech and language).9 Comprehensive cogni-
tive testing is laboriousandexpensive.Thesample size inmost
of these studies is small andoverestimates the effect size (type
I error) or fails to detect a difference (type II error).10,12 These
concerns are similar to the problemof postoperative cognitive
dysfunction in the elderly, with only insufficient tools avail-
able to reliably detect its presence.12 Therefore, it is essential
to ascertain under what circumstances individual cognitive
testing represents ameaningful human outcomemeasure.
Academic performance has a relevant and pragmatic ad-
vantage over such testing because of parental interest in how
their childperforms in school andbeyond.More important, are
cognitive test results really that different from academic per-
formance? Certainly, good school test scores require adequate
speech and learning skills. Good academic achievements are
complex and require continuous commitment to the educa-
tion, social andemotionalwell-being, andstabilityof thechild.
In this issue of JAMA Pediatrics, a Swedish nationwide
cohort study13 examining the birth cohorts from 1973 to 1993
reports academic achievement (school grades at age 16 years)
and cognitive performance (IQ for boys at military conscrip-
tionat age 18years). Exposedchildren (n = 33514)whohadun-
dergonea single anesthesia and surgerybefore age4years and
no subsequent hospitalization were compared with a control
groupofunexposedchildren (n = 159619)matchedonsex,ma-
ternal educational level, and year and month of birth. The
unique sample size of this study enables precise and robust
effect estimates.
Glatz et al13 state that surgical andanesthetic exposurebe-
fore age4yearshasminimal ornoeffect onacademic achieve-
ment or cognitive performance in adolescence. The authors
showed that a single exposure ormultiple exposures to anes-
thesia in early childhoodare several times (in somecases, 5-10
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times) less relevant to academic performance than sex, ma-
ternal educational level, or year andmonth of birth. These re-
sults are similar to those of other robust nationwide cohort
investigations.3Theyarealsoconsistentwith the recentlypub-
lished 2-year interim analysis of the General Anesthesia
Spinal (GAS) study,14which showed that sevoflurane anesthe-
sia for up to 1 hour in infancy (up to 60weeks’ postmenstrual
age) does not increase the risk of adverse neurodevelopmen-
tal outcomecomparedwith awake regional anesthesia. These
findings are also in line with a recent ambidirectional sibling
investigation (the Pediatric Anesthesia Neurodevelopment
Assessment [PANDA] study11) demonstrating similar IQ scores
in sibling pairs among whom one was exposed and the other
was unexposed to general anesthesia for inguinal hernia
repair before age 3 years.
There is an important message to be derived from the
study by Glatz et al.13 Neonates, infants, and young children
need and require important surgical procedures and inter-
ventions to be performed without any delay. The authors
highlight the need to rectify common ear, nose, and throat
problems early and not delay intervention until age 3 or 4
years, thus minimizing the effect of hearing deficits on the
development of speech and language skills. This statement
is particularly important given that ear, nose, and throat
procedures are the most common surgical procedures per-
formed in young children and that most of the supportive
observational studies on this topic include a high propor-
tion of children undergoing such procedures.
This study isalso reassuring forchildren,parents, andcare-
givers and puts the issue of anesthetic-related neurotoxicity
and the developing brain into perspective. Glatz et al13
elegantly demonstrated that many other factors are far more
important than anesthetic drug exposure in relation to long-
termneurocognitiveoutcomes.However, this findingdoesnot
automatically mean that anesthesia is “safe” in young chil-
drenas this termrefers to theconductofanesthesia rather than
the anesthetic drugsused.6,15 Also, these results cannot be ex-
trapolated to longer and more complex surgical procedures,
multiple anesthetics, and extremely premature infants.
Observational studies are plagued bymany confounding fac-
tors, and randomized clinical trials are complex and time
consuming. It will be difficult to achieve another similarly
large sample size within a realistic study period.
Ultimately, it seems unlikely that anesthetic drug expo-
sure in young children will be identified as correlating with
long-term neurocognitive outcomes. Attention must now be
directed to themore important environmental, medical, and
individual factors.6
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